Stock listing
NASDAQ:KRRO Korro Bio, Inc. Stock
Home listing (NASDAQ) of Korro Bio, Inc.
Follow Korro Bio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:KRRO
$14.32 USD +0.12 (+0.8%)
Close on Oct 30, 2026
- Day range
- $13.41 – $14.55 USDOct 30, 2026
- Volume
- 130,745 sharesOct 30, 2026
- Market cap
- $210.8M USDAt the close on Oct 30, 2026 · price × 14.73M shares outstanding
- 52-week range
- $5.20 – $42.70 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.84M USDMedian day 131,123 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:KRRO · Home | $14.32 USD | +0.115 (+0.8%) | 130,745 | $13.99 | $14.55 | $13.41 | $14.20 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:KRRO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $14.32 | +0.115 | +0.8% | $13.99 | $14.55 | $13.41 | 130,745 | |
| $14.20 | +0.34 | +2.5% | $13.86 | $14.28 | $13.65 | 147,684 | |
| $13.86 | +0.56 | +4.2% | $13.18 | $14.11 | $13.04 | 269,308 | |
| $13.30 | +1.28 | +10.6% | $12.73 | $13.95 | $12.41 | 322,652 | |
| $12.02 | +0.04 | +0.3% | $11.96 | $12.30 | $11.53 | 183,157 | |
| $11.98 | -0.07 | -0.6% | $12.04 | $12.49 | $11.28 | 237,437 | |
| $12.05 | +2.76 | +29.7% | $9.40 | $12.10 | $9.085 | 476,475 | |
| $9.29 | -0.15 | -1.6% | $9.47 | $9.77 | $9.22 | 115,999 | |
| $9.44 | +0.53 | +5.9% | $8.92 | $9.63 | $8.92 | 235,039 | |
| $8.91 | +0.42 | +4.9% | $8.58 | $8.94 | $8.36 | 134,873 | |
| $8.49 | -0.82 | -8.8% | $9.32 | $9.38 | $8.45 | 129,734 | |
| $9.31 | +0.43 | +4.8% | $8.93 | $9.78 | $8.53 | 440,177 | |
| $8.88 | +0.07 | +0.8% | $8.62 | $9.13 | $8.34 | 216,497 | |
| $8.81 | -0.56 | -6.0% | $9.37 | $9.39 | $8.545 | 263,653 | |
| $9.37 | -0.79 | -7.8% | $10.09 | $10.26 | $9.32 | 140,406 | |
| $10.16 | -0.42 | -4.0% | $10.60 | $10.78 | $10.13 | 133,510 | |
| $10.58 | +0.09 | +0.9% | $10.36 | $10.64 | $10.18 | 167,311 | |
| $10.49 | +0.73 | +7.5% | $9.64 | $10.64 | $9.50 | 156,998 | |
| $9.76 | -0.21 | -2.1% | $10.20 | $10.35 | $9.47 | 142,620 | |
| $9.97 | +0.33 | +3.4% | $9.70 | $10.10 | $9.41 | 112,218 | |
| $9.64 | -0.07 | -0.7% | $9.90 | $9.90 | $9.478 | 153,134 | |
| $9.71 | -0.20 | -2.0% | $9.93 | $10.27 | $9.465 | 88,781 | |
| $9.91 | +0.35 | +3.7% | $9.89 | $10.01 | $9.50 | 108,137 | |
| $9.56 | +0.05 | +0.5% | $9.56 | $9.80 | $9.30 | 92,876 | |
| $9.51 | -0.06 | -0.6% | $9.49 | $9.655 | $9.24 | 132,438 | |
| $9.57 | 0.00 | 0.0% | $9.64 | $9.64 | $9.40 | 114,420 | |
| $9.57 | -0.26 | -2.6% | $9.71 | $9.75 | $9.41 | 197,457 | |
| $9.83 | -0.51 | -4.9% | $10.31 | $10.31 | $9.55 | 224,715 | |
| $10.34 | +0.36 | +3.6% | $10.08 | $10.58 | $10.01 | 213,478 | |
| $9.98 | -0.04 | -0.4% | $10.12 | $10.77 | $9.86 | 290,519 | |
| $10.02 | -1.78 | -15.1% | $11.71 | $11.95 | $9.505 | 763,397 | |
| $11.80 | -2.03 | -14.7% | $14.18 | $14.36 | $11.76 | 400,440 | |
| $13.83 | -0.24 | -1.7% | $14.15 | $14.86 | $13.44 | 304,657 | |
| $14.07 | +0.19 | +1.4% | $13.87 | $14.20 | $12.98 | 162,602 | |
| $13.88 | +0.07 | +0.5% | $13.59 | $15.15 | $13.56 | 264,804 | |
| $13.81 | +0.75 | +5.7% | $13.28 | $14.06 | $13.17 | 197,974 | |
| $13.06 | +0.13 | +1.0% | $12.80 | $13.16 | $12.38 | 145,795 | |
| $12.93 | -0.58 | -4.3% | $13.44 | $13.76 | $12.87 | 131,501 | |
| $13.51 | +1.27 | +10.4% | $12.03 | $13.62 | $11.89 | 119,120 | |
| $12.24 | +0.62 | +5.3% | $11.53 | $12.30 | $11.53 | 78,430 | |
| $11.62 | -0.35 | -2.9% | $12.09 | $12.63 | $11.30 | 82,728 | |
| $11.97 | -0.27 | -2.2% | $12.26 | $12.78 | $11.82 | 81,069 | |
| $12.24 | -0.25 | -2.0% | $12.57 | $12.64 | $12.14 | 59,005 | |
| $12.49 | -0.42 | -3.3% | $12.78 | $13.04 | $12.28 | 87,957 | |
| $12.91 | -0.35 | -2.6% | $13.13 | $13.55 | $12.80 | 67,368 | |
| $13.26 | -0.42 | -3.1% | $13.62 | $13.69 | $13.24 | 48,569 | |
| $13.68 | -0.05 | -0.4% | $13.71 | $13.98 | $13.23 | 41,275 | |
| $13.73 | +0.66 | +5.0% | $13.14 | $13.90 | $13.14 | 79,709 | |
| $13.07 | -0.11 | -0.8% | $13.18 | $13.60 | $12.66 | 70,368 | |
| $13.18 | +0.22 | +1.7% | $13.02 | $13.56 | $13.02 | 45,706 | |
| $12.96 | -0.99 | -7.1% | $13.77 | $13.77 | $12.83 | 64,120 | |
| $13.95 | +0.73 | +5.5% | $13.50 | $14.19 | $13.50 | 140,967 | |
| $13.22 | +0.08 | +0.6% | $13.03 | $13.26 | $12.63 | 70,603 | |
| $13.14 | -0.14 | -1.1% | $13.11 | $13.72 | $12.88 | 78,579 | |
| $13.28 | -0.01 | -0.1% | $13.34 | $13.34 | $12.72 | 47,074 | |
| $13.29 | -0.06 | -0.4% | $13.39 | $13.93 | $12.89 | 113,827 | |
| $13.35 | +0.03 | +0.2% | $13.44 | $13.58 | $12.79 | 95,411 | |
| $13.32 | -0.17 | -1.3% | $13.61 | $14.00 | $13.28 | 109,843 | |
| $13.49 | +0.24 | +1.8% | $13.24 | $13.73 | $13.00 | 78,589 | |
| $13.25 | +1.13 | +9.3% | $12.24 | $13.30 | $12.24 | 120,198 | |
| $12.12 | +0.62 | +5.4% | $11.50 | $12.24 | $11.38 | 173,149 | |
| $11.50 | +0.15 | +1.3% | $11.46 | $11.70 | $11.19 | 105,842 | |
| $11.35 | +0.61 | +5.7% | $10.93 | $11.41 | $10.53 | 132,447 | |
| $10.74 | +0.37 | +3.6% | $10.46 | $10.88 | $10.22 | 94,695 | |
| $10.37 | -0.08 | -0.8% | $10.53 | $10.53 | $9.76 | 115,211 | |
| $10.45 | +0.38 | +3.8% | $10.26 | $10.59 | $10.00 | 129,702 |
- Ticker
- NASDAQ:KRRO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 26 slides
Latest news
Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency
Oct 22, 2026
Closed $12.05 (+29.7%) on Oct 22, 2026
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 16, 2026
Closed $8.91 (+4.9%) on Oct 19, 2026
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
Oct 5, 2026
Closed $9.76 (-2.1%) on Oct 6, 2026
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 6, 2026
Closed $12.12 (+5.4%) on Aug 6, 2026
Korro to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Closed $13.76 (+11.6%) on May 27, 2026
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency
May 20, 2026
Closed $10.01 (+9.4%) on May 20, 2026
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
May 19, 2026
Closed $9.15 (-8.2%) on May 19, 2026
Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 7, 2026
Closed $12.89 (-3.4%) on May 7, 2026
Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
Apr 16, 2026
Closed $13.47 (-1.5%) on Apr 16, 2026
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr 10, 2026
Closed $13.69 (+8.0%) on Apr 13, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 26 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 5 slides · May 19, 2026
Investor Day (January 2026)
Investor day · 54 slides · Jan 27, 2026
Investor Day (January 2026)
Investor day · 32 slides · Jan 27, 2026
Korro Bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 17 in the last 12 months · 105 in all · newest Oct 22, 2026 · oldest 2019
- Decks
- 6 decks · latest August 2026
Where Korro Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:KRRO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:KRRO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Korro Bio, Inc.